i-MoMCARE:创新移动技术用于柬埔寨妇幼保健——整群随机对照试验研究方案
柬埔寨政府于2003年建立村卫生支持小组(VHSGs)以协助基层妇幼保健(MCH)服务,但VHSGs面临缺乏定期结构化培训与报酬、卫生中心支持督导有限且不一致等挑战。i-MoMCARE为双臂整群随机对照试验,于2022至2025年开展,将五个运行区随机分配至干预组、另五个至对照组,干预持续24个月,干预组约200名VHSGs配备移动应用程序作为工作辅助、20名卫生中心工作人员配备网络界面以改善对VHSGs的支持与督导。主要结局为由孕产妇与新生儿照护指标、儿童免疫及两岁以下儿童治疗构成的复合MCH指数,将进行意向性分析与符合方案分析,并开展定性访谈与成本效果分析。
要点
- i-MoMCARE为双臂整群随机对照试验,五个运行区分配至干预组、五个至对照组,干预持续24个月。
- 干预组约200名VHSGs配备移动应用程序作为工作辅助,20名卫生中心工作人员配备网络界面以改善支持与督导。
- 主要结局为复合MCH指数,由孕产妇与新生儿照护指标、儿童免疫及两岁以下儿童治疗构成。
核心结论
- i-MoMCARE预期将增加柬埔寨农村地区MCH服务的可及性与覆盖率,并有助于推进数字健康在基层医疗干预中的应用,该应用在该国仍处于起步阶段。
- 研究结果将为不断增多的关于移动健康改善农村低中收入国家MCH服务覆盖有效性及可行性的文献提供有价值的补充。
研究设计与样本
- i-MoMCARE为双臂整群随机对照试验,于2022年至2025年开展。
- 五个运行区被随机分配至干预组,另五个运行区分配至对照组,干预持续24个月。
- 干预组约200名VHSGs配备移动应用程序作为工作辅助,20名卫生中心工作人员配备网络界面以改善对VHSGs的支持与督导。
- 潜在受益者包括孕妇、母亲及两岁以下儿童,在基线与终点测量结局。
- 将进行意向性分析与符合方案分析,并对选定的受益者与利益相关者进行定性访谈以评估干预的可接受性、可行性与可扩展性。
关键数值与推荐
- 主要结局为复合MCH指数,由孕产妇与新生儿照护指标、儿童免疫及两岁以下儿童治疗构成。
- 次要结局包括选定MCH服务的覆盖率。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Government of Cambodia established the village health support groups (VHSGs) in 2003 to facilitate primary healthcare activities, including maternal and child health (MCH) services. However, VHSGs face several challenges that hinder them from performing optimally, including a lack of regular structured training and remuneration and limited and inconsistent support and supervision from the health centers (HCs). This implementation research aims to develop, implement, and evaluate a digital health intervention to improve the performance of VHSGs through better support and supervision and increase the MCH service coverage in rural Cambodia. METHODS: i-MoMCARE, a two-arm cluster randomized controlled trial, will be conducted between 2022 and 2025. Five operational districts (ODs) have been randomized to an intervention arm and the other five ODs to the control arm. The intervention will last for 24 months. Around 200 VHSGs in the intervention arm will be equipped with a mobile application as a job aid and 20 HC staff with a web interface to improve support and supervision of VHSGs. The potential beneficiaries will include pregnant women, mothers, and children under 2 years old. We will measure the outcomes at baseline and endline. The primary outcomes will consist of a composite MCH index constructed from maternal and newborn care indicators, child immunization, and treatment of under-two children. Secondary outcomes will include coverage of selected MCH services. We will conduct the intention-to-treat and per-protocol analyses. We will conduct qualitative interviews with selected beneficiaries and stakeholders to evaluate the intervention's acceptability, feasibility, and scalability. We will also conduct a cost-effective analysis using decision-analytic modeling incorporating a societal perspective that explores different time horizons, intervention effects, and when scaled up to the national level. DISCUSSION: i-MoMCARE is expected to increase MCH service access and coverage in rural Cambodia. It will contribute to advancing digital health use in primary healthcare interventions, which remains in its infancy in the country. Furthermore, the study findings will be a valuable addition to a growing body of literature on the effectiveness and feasibility of mobile health to improve coverage of MCH services in rural low- and middle-income country settings. TRIAL REGISTRATION: ClinicalTrial.gov NCT05639595. Registered on 06 December 2022.
引用
- Saing CH, Ung M, Suy S, et al. i-MoMCARE: Innovative Mobile Technology for Maternal and Child Health Care in Cambodia-study protocol of a cluster randomized controlled trial. Trials. 2023. PMID: 37880782. doi:10.1186/s13063-023-07724-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。